All In Biotech

Free tool

FAERS Monitor: Loseasonique

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022262 or its brand name (Loseasonique, Ethinyl Estradiol, Levonorgestrel). Reports on generic versions are filed under their own applications.

Reports

47

Serious

19

40% of reports

Hospitalization

6

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • condition aggravated4
  • dizziness4
  • drug ineffective4
  • nausea4
  • suicidal ideation4
  • anxiety3
  • depression3
  • fatigue3
  • tremor3
  • exposure during pregnancy2
  • feeling abnormal2
  • headache2
  • irritability2
  • memory impairment2
  • nasopharyngitis2

Reports by year received

View as table
YearReports
20141
20154
201613
20176
20187
20196
20204
20222
20232
20241
20251

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,112 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
suicidal ideationSignal419.67.753
irritability214.93.814
exposure during pregnancy214.43.713
tremorSignal38.12.712
memory impairment26.51.75
depressionSignal35.92.08
condition aggravatedSignal45.92.312
nasopharyngitis24.91.33
anxietySignal34.71.66
feeling abnormal23.71.02
dizzinessSignal43.61.45
nausea42.30.92
fatigue31.70.60
headache21.40.40
drug ineffective41.40.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.